Quantcast
Home > Quotes > CTXRW

Citius Pharmaceuticals, Inc. Warrant (CTXRW) Quote & Summary Data

CTXRW 
$0.117
*  
unch
unch
Get CTXRW Alerts
*Delayed - data as of Dec. 13, 2018  -  Find a broker to begin trading CTXRW now
Exchange:NASDAQ
Industry: Health Care
Community Rating:
View:    CTXRW Pre-Market
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks

Key Stock Data

Best Bid / Ask
N/A / N/A
1 Year Target
Today's High / Low
N/A / N/A
Share Volume
0
50 Day Avg. Daily Volume
N/A
Previous Close
$ 0.117
52 Week High / Low
$ 1.38 / $ 0.0601
Market Cap
Annualized Dividend
N/A
Ex Dividend Date
N/A
Dividend Payment Date
N/A
Current Yield
0 %
Beta
0

Intraday Chart

Shares Traded

Share Volume:
0
50 Day Avg. Daily Volume:
N/A

Trading Range

The current last sale of $0.117 is 94.68% Higher than the 52 week low.

Intraday Last 52 Weeks
High: N/A $ 1.38
 Low: N/A $ 0.0601

Company Description (as filed with the SEC)

Citius Pharmaceuticals, Inc., headquartered in Cranford, New Jersey, is a specialty pharmaceutical company dedicated to the development and commercialization of critical care products targeting important medical needs with a focus on anti-infective products in adjunct cancer care and unique prescription products. Our goal is to achieve leading market positions by providing therapeutic products that address unmet medical needs yet have a lower development risk than is associated with new chemical entities. New formulations or combinations of previously approved drugs with substantial existing safety and efficacy data are a core focus as we seek to reduce development and clinical risks associated with drug development. Our strategy centers on products that have intellectual property and regulatory exclusivity protection, while providing competitive advantages over other existing therapeutic approaches.  ... More ...  

Nasdaq Official Price

Open Price:
N/A
Open Date:
N/A
Close Price:
N/A
Close Date:
N/A

Research Brokers before you trade

Want to trade FX?

Analyst Info